These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 9041322

  • 21. A Recombinant Measles Vaccine with Enhanced Resistance to Passive Immunity.
    Julik E, Reyes-Del Valle J.
    Viruses; 2017 Sep 21; 9(10):. PubMed ID: 28934110
    [Abstract] [Full Text] [Related]

  • 22. Modulation of disease, T cell responses, and measles virus clearance in monkeys vaccinated with H-encoding alphavirus replicon particles.
    Pan CH, Valsamakis A, Colella T, Nair N, Adams RJ, Polack FP, Greer CE, Perri S, Polo JM, Griffin DE.
    Proc Natl Acad Sci U S A; 2005 Aug 16; 102(33):11581-8. PubMed ID: 16037211
    [Abstract] [Full Text] [Related]

  • 23. Use of Vaxfectin adjuvant with DNA vaccine encoding the measles virus hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques against measles virus.
    Pan CH, Jimenez GS, Nair N, Wei Q, Adams RJ, Polack FP, Rolland A, Vilalta A, Griffin DE.
    Clin Vaccine Immunol; 2008 Aug 16; 15(8):1214-21. PubMed ID: 18524884
    [Abstract] [Full Text] [Related]

  • 24. DNA vaccination of infants in the presence of maternal antibody: a measles model in the primate.
    Premenko-Lanier M, Rota PA, Rhodes G, Verhoeven D, Barouch DH, Lerche NW, Letvin NL, Bellini WJ, McChesney MB.
    Virology; 2003 Mar 01; 307(1):67-75. PubMed ID: 12667815
    [Abstract] [Full Text] [Related]

  • 25. Clinical measles after measles virus challenge in simian immunodeficiency virus-infected measles virus-vaccinated rhesus monkeys.
    Permar SR, Rao SS, Sun Y, Bao S, Buzby AP, Kang HH, Letvin NL.
    J Infect Dis; 2007 Dec 15; 196(12):1784-93. PubMed ID: 18190259
    [Abstract] [Full Text] [Related]

  • 26. Protection against challenge with measles virus (MV) in infant macaques by an MV DNA vaccine administered in the presence of neutralizing antibody.
    Premenko-Lanier M, Rota PA, Rhodes GH, Bellini WJ, McChesney MB.
    J Infect Dis; 2004 Jun 01; 189(11):2064-71. PubMed ID: 15143474
    [Abstract] [Full Text] [Related]

  • 27. Prior DNA vaccination does not interfere with the live-attenuated measles vaccine.
    Premenko-Lanier M, Rota P, Rhodes G, Bellini W, McChesney M.
    Vaccine; 2004 Jan 26; 22(5-6):762-5. PubMed ID: 14741170
    [Abstract] [Full Text] [Related]

  • 28. Use of cotton rats for preclinical evaluation of measles vaccines.
    Wyde PR, Stittelaar KJ, Osterhaus AD, Guzman E, Gilbert BE.
    Vaccine; 2000 Aug 15; 19(1):42-53. PubMed ID: 10924785
    [Abstract] [Full Text] [Related]

  • 29. Live-attenuated measles virus vaccine targets dendritic cells and macrophages in muscle of nonhuman primates.
    Rennick LJ, de Vries RD, Carsillo TJ, Lemon K, van Amerongen G, Ludlow M, Nguyen DT, Yüksel S, Verburgh RJ, Haddock P, McQuaid S, Duprex WP, de Swart RL.
    J Virol; 2015 Feb 15; 89(4):2192-200. PubMed ID: 25473055
    [Abstract] [Full Text] [Related]

  • 30. Generation of a More Immunogenic Measles Vaccine by Increasing Its Hemagglutinin Expression.
    Julik E, Reyes-Del Valle J.
    J Virol; 2016 Jun 01; 90(11):5270-5279. PubMed ID: 26984727
    [Abstract] [Full Text] [Related]

  • 31. Vaccination against acute respiratory virus infections and measles in man.
    Osterhaus AD, de Vries P.
    Immunobiology; 1992 Feb 01; 184(2-3):180-92. PubMed ID: 1587542
    [Abstract] [Full Text] [Related]

  • 32. A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform.
    Malczyk AH, Kupke A, Prüfer S, Scheuplein VA, Hutzler S, Kreuz D, Beissert T, Bauer S, Hubich-Rau S, Tondera C, Eldin HS, Schmidt J, Vergara-Alert J, Süzer Y, Seifried J, Hanschmann KM, Kalinke U, Herold S, Sahin U, Cichutek K, Waibler Z, Eickmann M, Becker S, Mühlebach MD.
    J Virol; 2015 Nov 01; 89(22):11654-67. PubMed ID: 26355094
    [Abstract] [Full Text] [Related]

  • 33. Vaxfectin adjuvant improves antibody responses of juvenile rhesus macaques to a DNA vaccine encoding the measles virus hemagglutinin and fusion proteins.
    Lin WH, Vilalta A, Adams RJ, Rolland A, Sullivan SM, Griffin DE.
    J Virol; 2013 Jun 01; 87(12):6560-8. PubMed ID: 23552419
    [Abstract] [Full Text] [Related]

  • 34. Enteric administration of a live attenuated measles vaccine does not induce protective immunity in a macaque model.
    Stittelaar KJ, de Swart RL, Vos HW, van Amerongen G, Agafonov AP, Nechaeva EA, Osterhaus AD.
    Vaccine; 2002 Jul 26; 20(23-24):2906-12. PubMed ID: 12126901
    [Abstract] [Full Text] [Related]

  • 35. Use of a Recombinant Gamma-2 Herpesvirus Vaccine Vector against Dengue Virus in Rhesus Monkeys.
    Bischof GF, Magnani DM, Ricciardi M, Shin YC, Domingues A, Bailey VK, Gonzalez-Nieto L, Rakasz EG, Watkins DI, Desrosiers RC.
    J Virol; 2017 Aug 15; 91(16):. PubMed ID: 28592531
    [Abstract] [Full Text] [Related]

  • 36. Measles in the cynomolgus monkey (Macaca fascicularis).
    Welshman MD.
    Vet Rec; 1989 Feb 25; 124(8):184-6. PubMed ID: 2929098
    [Abstract] [Full Text] [Related]

  • 37. HIV-1 vaccines based on replication-competent Tiantan vaccinia protected Chinese rhesus macaques from simian HIV infection.
    Liu Q, Li Y, Luo Z, Yang G, Liu Y, Liu Y, Sun M, Dai J, Li Q, Qin C, Shao Y.
    AIDS; 2015 Mar 27; 29(6):649-58. PubMed ID: 25849828
    [Abstract] [Full Text] [Related]

  • 38. Priming of measles virus-specific humoral- and cellular-immune responses in macaques by DNA vaccination.
    Stittelaar KJ, de Swart RL, Vos HW, van Amerongen G, Sixt N, Wild TF, Osterhaus AD.
    Vaccine; 2002 May 15; 20(16):2022-6. PubMed ID: 11972970
    [Abstract] [Full Text] [Related]

  • 39. Construction of vaccinia virus recombinants expressing several measles virus proteins and analysis of their efficacy in vaccination of mice.
    Wild TF, Bernard A, Spehner D, Drillien R.
    J Gen Virol; 1992 Feb 15; 73 ( Pt 2)():359-67. PubMed ID: 1538193
    [Abstract] [Full Text] [Related]

  • 40. Protection of mice from fatal measles encephalitis by vaccination with vaccinia virus recombinants encoding either the hemagglutinin or the fusion protein.
    Drillien R, Spehner D, Kirn A, Giraudon P, Buckland R, Wild F, Lecocq JP.
    Proc Natl Acad Sci U S A; 1988 Feb 15; 85(4):1252-6. PubMed ID: 3422488
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.